| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $8.97M | +10.3K | +55.74% | $868.88 | 28.8K | Feb 10, 2025 | Direct | |
| holding | LLY | Common Stock | 14.7K | Feb 10, 2025 | By Anat Hakim SLAT | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +6.7K | $0.00 | 6.7K | Feb 10, 2025 | Common Stock | 6.7K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |